Should I buy or sell 908 Devices stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MASS shares. View MASS analyst ratings or view top-rated stocks .

What is 908 Devices' stock price target for 2024?

2 Wall Street research analysts have issued 12-month target prices for 908 Devices' stock. Their MASS share price targets range from $14.00 to $20.00. On average, they predict the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 128.2% from the stock's current price. View analysts price targets for MASS or view top-rated stocks among Wall Street analysts .

How have MASS shares performed in 2023?

908 Devices' stock was trading at $7.62 at the beginning of the year. Since then, MASS stock has decreased by 2.2% and is now trading at $7.45. View the best growth stocks for 2023 here .

When is 908 Devices' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024. View our MASS earnings forecast .

How were 908 Devices' earnings last quarter?

908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.30) by $0.08. The company earned $14.30 million during the quarter, compared to analysts' expectations of $13.45 million. 908 Devices had a negative net margin of 81.57% and a negative trailing twelve-month return on equity of 21.67%. The firm's revenue for the quarter was down 9.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.20) EPS.

What ETFs hold 908 Devices' stock?

ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include Alger 35 ETF (ATFV) and ARK Genomic Revolution ETF (ARKG) . Direxion Moonshot Innovators ETF (MOON) .

What guidance has 908 Devices issued on next quarter's earnings?

908 Devices issued an update on its FY 2023 earnings guidance on Tuesday, November, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $49.00 million-$51.00 million, compared to the consensus revenue estimate of $50.19 million.

When did 908 Devices IPO?

(MASS) raised $101 million in an initial public offering (IPO) on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO.

Who are 908 Devices' major shareholders?

908 Devices' stock is owned by a number of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.41%), Ameriprise Financial Inc. (5.79%), Fred Alger Management LLC (4.11%), Platinum Investment Management Ltd. (2.58%), Sumitomo Mitsui Trust Holdings Inc. (1.95%) and AWM Investment Company Inc. (1.73%). Insiders that own company stock include Christopher D Brown, Christopher D Brown , E Kevin Hrusovsky, John Kenneweg , Joseph H Iv Griffith , Kevin J Knopp , Mark Spoto, Michael S Turner, Nicolas Barthelemy , Trent A Basarsky, Trent A Basarsky and Venture Fund Vii LP Arch. View institutional ownership trends .

How do I buy shares of 908 Devices?

Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

908 Devices Stock Price, News & Analysis (NASDAQ:MASS)

$7.45

+0.30 (+4.20%)

(As of 01:11 PM ET)

Compare

Today's Range: $7.05
▼
$7.49
50-Day Range: $4.96
▼
$8.20
52-Week Range: $4.85
▼
$10.97

Volume: 30,009 shs
Average Volume: 215,870 shs
Market Capitalization: $241.22 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.00

908 Devices MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 128.2% Upside
$17.00 Price Target
Short Interest: Bearish
6.04% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Medical Sector

676th out of 949 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

6th out of 10 stocks

3.5

Analyst's Opinion

Consensus Rating
908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $17.00, 908 Devices has a forecasted upside of 128.2% from its current price of $7.45.
Amount of Analyst Coverage
908 Devices has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.04% of the float of 908 Devices has been sold short.
Short Interest Ratio / Days to Cover
908 Devices has a short interest ratio ("days to cover") of 9.3.
Change versus previous month
Short interest in 908 Devices has recently increased by 3.68%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
908 Devices does not currently pay a dividend.
Dividend Growth
908 Devices does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MASS.

0.6

News and Social Media Coverage

Search Interest
Only 2 people have searched for MASS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
2 people have added 908 Devices to their MarketBeat watchlist in the last 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 908 Devices insiders have not sold or bought any company stock.
Percentage Held by Insiders
27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
65.74% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Earnings Growth
Earnings for 908 Devices are expected to remain at ($1.20) per share in the coming year.
Price to Earnings Ratio vs. the Market
The P/E ratio of 908 Devices is -6.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of 908 Devices is -6.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
908 Devices has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About 908 Devices Stock (NASDAQ:MASS)

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MASS Stock News Headlines

November 28, 2023 | seekingalpha.com

908 Devices: Situation Getting Worse

November 14, 2023 | finance.yahoo.com

908 Devices Announces MX908 Integration Capabilities

December 6, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 9, 2023 | finance.yahoo.com

908 Devices Inc. (NASDAQ:MASS) Q3 2023 Earnings Call Transcript

November 9, 2023 | markets.businessinsider.com

908 Devices’ Strong Q3 Performance and New Product Pipeline Drive Analyst’s Buy Rating

November 7, 2023 | finance.yahoo.com

908 Devices Inc (MASS) Reports 9% Decrease in Q3 2023 Revenue, Narrows Full-Year Outlook

November 7, 2023 | msn.com

908 Devices beats Q3 top and bottom line estimates; updates FY23 outlook

November 7, 2023 | finance.yahoo.com

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

December 6, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 6, 2023 | msn.com

908 Devices Q3 2023 Earnings Preview

November 6, 2023 | finance.yahoo.com

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

October 24, 2023 | msn.com

908 Devices awarded $10.4M order from U.S. Air Force for its handheld MX908 device

October 24, 2023 | finance.yahoo.com

908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device

October 24, 2023 | finance.yahoo.com

908 Devices to Report Third Quarter Financial Results on November 7, 2023

October 12, 2023 | bizjournals.com

Durham firm appoints CEO to steer commercial efforts, plans to hire

September 26, 2023 | msn.com

Stephens & Co. Reiterates 908 Devices (MASS) Overweight Recommendation

September 18, 2023 | finance.yahoo.com

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

September 15, 2023 | finance.yahoo.com

908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase

August 31, 2023 | msn.com

908 Devices: Not Worth Investing

August 8, 2023 | marketwatch.com

908 Devices Shares Rise After 2Q Results

August 8, 2023 | benzinga.com

Earnings Preview: 908 Devices

August 8, 2023 | finance.yahoo.com

908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook

August 7, 2023 | finance.yahoo.com

908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program

July 31, 2023 | finance.yahoo.com

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

July 25, 2023 | finance.yahoo.com

908 Devices to Report Second Quarter Financial Results on August 8, 2023

July 16, 2023 | finance.yahoo.com

Investors in 908 Devices (NASDAQ:MASS) have unfortunately lost 59% over the last year

July 13, 2023 | finance.yahoo.com

908 Devices Inc. (MASS) Soars 8.5%: Is Further Upside Left in the Stock?

See More Headlines

Receive MASS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/05/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Measuring & controlling devices, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MASS
CUSIP: N/A
CIK: 1555279
Web: www.908devices.com
Phone: 857-254-1500
Fax: N/A
Employees: 227
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $17.00
High Stock Price Target: $20.00
Low Stock Price Target: $14.00
Potential Upside/Downside: +137.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.21)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-33,560,000.00
Net Margins: -81.57%
Pretax Margin: -81.90%
Return on Equity: -21.67%
Return on Assets: -17.61%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.06
Quick Ratio: 7.34

Sales & Book Value

Annual Sales: $47.52 million
Price / Sales: 4.87
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.03 per share
Price / Book: 1.19

Miscellaneous

Outstanding Shares: 32,379,000
Free Float: 23,378,000
Market Cap: $231.51 million
Optionable: Not Optionable
Beta: 0.77

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Dr. Kevin J. Knopp Ph.D. (Age 50)
Co-Founder, CEO, President & Director
Comp: $788.88k
Dr. Christopher David Brown Ph.D. (Age 48)
Co-Founder, Chief Product Officer & Member of Scientific Advisory Board
Comp: $459.7k
Mr. Joseph H. Griffith IV (Age 48)
CFO & Treasurer
Comp: $468.98k
Mr. Steve Araiza
Co-Founder
Mr. Andrew Bartfay
Co-Founder & Director of Hardware Development
Mr. Michael Jobin
Co-Founder & Director of Product Development
Dr. Scott Miller Ph.D.
Co-founder & Director of MS Engineering
Mr. Michael S. Turner Esq. (Age 56)
J.D., Chief Legal & Administrative Officer and Secretary
Comp: $97.84k
Mr. Don Osmer (Age 58)
Vice President of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MASS Stock Analysis - Frequently Asked Questions

Should I buy or sell 908 Devices stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MASS shares.
View MASS analyst ratings or view top-rated stocks.
What is 908 Devices' stock price target for 2024?: 2 Wall Street research analysts have issued 12-month target prices for 908 Devices' stock. Their MASS share price targets range from $14.00 to $20.00. On average, they predict the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 128.2% from the stock's current price.
View analysts price targets for MASS or view top-rated stocks among Wall Street analysts.
How have MASS shares performed in 2023?: 908 Devices' stock was trading at $7.62 at the beginning of the year. Since then, MASS stock has decreased by 2.2% and is now trading at $7.45.
View the best growth stocks for 2023 here.
When is 908 Devices' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024.
View our MASS earnings forecast.
How were 908 Devices' earnings last quarter?: 908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.30) by $0.08. The company earned $14.30 million during the quarter, compared to analysts' expectations of $13.45 million. 908 Devices had a negative net margin of 81.57% and a negative trailing twelve-month return on equity of 21.67%. The firm's revenue for the quarter was down 9.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.20) EPS.
What ETFs hold 908 Devices' stock?: ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include Alger 35 ETF (ATFV) and ARK Genomic Revolution ETF (ARKG).Direxion Moonshot Innovators ETF (MOON).

What guidance has 908 Devices issued on next quarter's earnings?: 908 Devices issued an update on its FY 2023 earnings guidance on Tuesday, November, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $49.00 million-$51.00 million, compared to the consensus revenue estimate of $50.19 million.
When did 908 Devices IPO?: (MASS) raised $101 million in an initial public offering (IPO) on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO.
Who are 908 Devices' major shareholders?: 908 Devices' stock is owned by a number of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.41%), Ameriprise Financial Inc. (5.79%), Fred Alger Management LLC (4.11%), Platinum Investment Management Ltd. (2.58%), Sumitomo Mitsui Trust Holdings Inc. (1.95%) and AWM Investment Company Inc. (1.73%). Insiders that own company stock include Christopher D Brown, Christopher D Brown, E Kevin Hrusovsky, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Mark Spoto, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky, Trent A Basarsky and Venture Fund Vii LP Arch.
View institutional ownership trends.
How do I buy shares of 908 Devices?: Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:MASS) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial